Physician Wealth Advisors’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.93K Hold
182
– – ﹤0.01% 1375
2026
Q2
$6.04K Hold
182
– – ﹤0.01% 1022
2026
Q1
$4.53K Hold
182
– – ﹤0.01% 1041
2025
Q4
$2.11K Buy
182
+52
+40% +$493 ﹤0.01% 1274
2025
Q3
$1.13K Hold
130
– – ﹤0.01% 1505
2025
Q2
$931 Hold
130
– – ﹤0.01% 1480
2025
Q1
$849 Buy
+130
New +$2.05K ﹤0.01% 1201

Other funds holding STRO

Physician Wealth Advisors's STRO Position: Q3 2026 in Review

Physician Wealth Advisors held its Sutro Biopharma (STRO) position steady in Q3 2026 at 182 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Physician Wealth Advisors first reported a position in STRO in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.04K in Q2 2026. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Physician Wealth Advisors held 182 shares of Sutro Biopharma worth $2.93K as of Q3 2026.
  • Physician Wealth Advisors left its Sutro Biopharma share count unchanged in Q3 2026.
  • Sutro Biopharma made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1375 holding.
  • Physician Wealth Advisors first reported a position in Sutro Biopharma in Q1 2025 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Sutro Biopharma position peaked at $6.04K in Q2 2026.
  • 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.